Context Therapeutics Investor Presentation Deck slide image

Context Therapeutics Investor Presentation Deck

Investment Highlights 2 Large Unmet Need Female Cancers 24 Context Therapeutics Inc. - Sept. 2022 S High-Value Targets Progesterone Receptor and Claudin 6 K Near-Term Milestones Multiple Data Readouts in Q4 2022 Strong Team Deep Domain Experience, Track Record of Success Corporate Ti # Financial Strength Expected Cash Runway into Q1 2024
View entire presentation